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Objective: Recent data suggest that obesity and related metabolic aberrations are associated with oste-
oarthritis (OA) development, a phenomenon that is attributed at least in part to the consumption of lipid-
rich diets. To date, the molecular mechanisms that govern the lipid-OA connection remain largely
unknown. Given the important role of high-density lipoprotein (HDL) in plasma and tissue lipid
metabolism, the main purpose of the present study was to investigate the role of HDL metabolism in the
pathobiology of OA.
Methods:We used apolipoprotein A-I (apoA-I)/ mice that lack classical apoA-I containing HDL, LCAT/
mice that have only immature HDL and relatively reduced HDL-cholesterol levels and control C57BL/6
mice. Mice were placed on chow or western-type (WTD) and monitored for 24 weeks. Knee joints were
removed and articular cartilage was isolated for further analyses.
Results: The LCAT/ mice were signiﬁcantly more sensitive to the development of diet-induced obesity
compared to the C57BL/6 and apoA-I/ mice. Morphological, biochemical and molecular analyses
revealed that the LCAT/ obese mice developed OA, while the C57BL/6 mice that were fed WTD did not.
Notably, apoA-I/ mice that received WTD also developed OA although their body-weight gain was
similar to their wild-type counterparts. Interestingly, bone marrow from LCAT/ and apoA-I/ mice
contained signiﬁcantly increased number of adipocytes, compared to the other groups.
Conclusions: Our ﬁndings suggest that perturbations in HDL metabolism predispose to OA following
chronic insult with WTD and raise the challenging possibility that HDL has a causative relation to OA in
patients with metabolic syndrome.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a very common degenerative joint disease
that accounts for a considerable proportion of disability in adults1.
The atiology of OA is multifactorial, inasmuch as increased
mechanical stimulation, trauma, metabolic factors and genetic
susceptibility contribute to its pathogenesis. Deﬁnitely, one of the
most common conditions that lead to OA is obesity. Excess body-
weight is associated with elevated mechanical stimulation of the
weigh-bearing joints that leads to cartilage destruction and.J. Papachristou, Department
oft Tissue Studies, University
-Patras, Patras 26500, Greece.
pachristoudj@med.upatras.gr
s Research Society International. Pultimately OA development2. Notably, however, even though
a connection between obesity and OA is well-established, the
contribution of excessive body-weight to OA development
remains vague. Indeed, several epidemiological studies have
demonstrated that aside from the large weight-bearing joints like
knee and hip, the small non-bearing articulations of the hand of
obese individuals also develop OA, a ﬁnding that cannot be
attributed to increased body-weight3,4. Along the same lines,
another recent study on obese patients showed an association
between obesity and hand OA that was independent of other
metabolic parameters raising the possibility that altered lipid
metabolism has a cardinal role in OA pathogenesis5. This
hypothesis is further supported by a considerable volume of
reports having shown that OA is tightly associated with
cardiovascular-related conditions, such as hypertension, hyper-
cholesterolemia, abdominal obesity, dyslipidemia, type 2 diabetes
and metabolic syndrome, which are coupled to distorted lipidublished by Elsevier Ltd. All rights reserved.
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that high-density lipoprotein cholesterol (HDL-C) is decreased in
the serum of OA patients compared to non-OA individuals, clearly
suggesting a potential relationship between HDL and OA
aetiopathogenesis7,8.
HDL, a key-component of the lipoprotein transport system
possesses a number of functions associated with maintenance of
plasma and tissue lipid metabolism and homeostasis. The
biogenesis of mature HDL requires apolipoprotein A-I (apoA-I)
and the functions of lipid transporter ABCA1 and plasma enzyme
lecithin:cholesterol acyltransferase (LCAT). LCAT is a critical
component of the lipoprotein metabolic system. It is produced
and secreted mainly by the liver and catalyzes the esteriﬁcation of
free cholesterol of lipoproteins by transferring a fatty-acyl group
from the C-2 position of lecithin to the 3-hydroxyl group of
cholesterol9. In plasma, LCAT is activated by apoA-I. Following
initial lipidation of apoA-I by ABCA1, apoA-I forms discoidal
particles that are then converted to mature, fully active, spherical
HDL by the action of LCAT10. It has been recently reported that
LCAT is a key enzyme in the metabolism of triglyceride-rich
lipoproteins11, while apoA-I or LCAT deﬁciency sensitizes mice
to hepatic lipid deposition associated with non-alcoholic fatty
liver disease12,13.
In metabolic syndrome, obesity is associated with dyslipidemia
consisting of increased triglyceride and reduced HDL-cholesterol
levels. Based on the recently uncovered link between obesity and
OA in patients with metabolic syndrome7,8, in the present study we
sought to investigate the potential link between HDL metabolic
pathway and the pathogenesis of OA.
Methods
Animal studies
We used male 10e12-week-old LCAT-deﬁcient (LCAT/) mice
(Dr. Silvia Santamarina-Fojo laboratory14) as well as apoA-I-
deﬁcient (apoA-I/) and C57BL/6 mice (Jackson Labs, Bar Harbor,
Maine, USA) that were caged individually and allowed unrestricted
access to food and water. The age and starting body-weights of the
tested animals were similar. Mice were fed the standard western-
type diet (WTD) and standard chow diet (CD) (both form Muce-
dola SRL, Italy) for the indicated period. The standard WTD (42%
energy from fat) is composed of 17.3% protein, 48.5% carbohydrate,
21.2% fat, 0.2% (0.15% added, 0.05% from fat source), and contains
4.5 kcal/g. The standard CD (10% energy from fat) is composed of
29.0% protein, 60.4% carbohydrates and 10.6% fat. Body-weight was
measured at the indicated time-points after diet initiation12. At the
end of each experiment, mice were sacriﬁced and plasma and knee
joints were collected for biochemical, histological and molecular
analyses. Carcasses were stored at 80C. All animal studies were
performed according to the EU guidelines for the Protection and
Welfare of Animals. The work was approved by Committee of the
Laboratory Animal Center of The University of Patras Medical
School and the Veterinary Authority of the Prefecture of Western
Greece.
Fractionation of plasma lipoproteins by density gradient
ultracentrifugation
In order to determine plasma cholesterol and triglyceride levels
in various plasma lipoproteins, 0.5 ml of pools of plasma from six
LCAT/, six apoA-I and six C57BL/6 mice were fractionated by
density gradient ultracentrifugation as previously described12,15.
The cholesterol and triglyceride content of different density frac-
tions were determined as described above.Determination of daily food consumption
Food intake was assessed by determining the difference in food
weight during a 7-day period to ensure reliable measurements,
as described previously16,17. Results were then expressed as
average food consumption per mouse per strain over the 7-day
period  standard error of the mean.
Histological analysis of tissue samples
At the end of each experiment, mice were sacriﬁced. Hyaline
cartilage from femora and tibiae was isolated under direct inspec-
tionwith a Nikon SMZ660 stereomicroscope, ﬁnely diced and stored
at 80C or ﬁxed in 10% formalin for molecular/biochemical and
histological analyses, respectively. Fixed sections were decalciﬁed
with Ethylenediaminetetraacetic acid (EDTA), embedded in parafﬁn
and sectioned at 4 mm for histological evaluation. Hematoxyline and
eosin (H&E) stain was applied for the assessment of articular
cartilage and bone marrow micromorphology. Five serial sections
were obtained from one knee joint of each animal. In order to assess
cartilaginous tissue structural integrity matrix proteoglycans were
visualized with the use of the Safranin O/Fast green histochemical
stain according to the manufacturer’s instructions (S8884, Sigma)
and observed with Olympus BX41 bright-ﬁeld microscope. OA
changes were graded semi-quantitatively in a blindfolded manner
by one bone-and-soft-tissue pathologist (DJP) and one investigator
(I-ET) on a scale from 0 to 6 according to the scoring system criteria
recommended by the Osteoarthritis Research Society International
(OARSI)18. The severity of the OA changes is expressed as maximal
scores for the entire joint18. For the calculation of the number of
bone marrow adipocytes ﬁve different areas per section were
photographed using a Nikon Eclipse 80i microscope with a Nikon
DXM 1200C digital camera (original magniﬁcation 10). The digital
images were imported into Photoshop CS4 and grid was added. For
each area the number of lipid vacuoles that were intersected by the
gridwas determined and calculated blindly by DJP and I-ET. For each
animal the average score was used for statistical analysis.
Micro-computer tomography (mCT) analysis
Fixed knee joints were mounted on the CT specimen tube for
scanning at a resolution of 12 mm, with a slice increment of 10 mm
(Scanco vivaCT 40 in vivo mCT scanner, Scanco Medical AG,
Switzerland). Reconstructed 3D mCT scans were evaluated for the
detection of knee cartilage architectural alterations.
Protein extraction
Knee cartilage derived from C57BL/6, apoA-I/ and LCAT/
mice, fed withWTD or CD was used for the determination of matrix
metalloproteases (MMPs) expression. As mentioned previously,
each specimen was ﬁnely diced and the macromolecules contained
were extracted for 24 h at 4C in the dark with 4 M GdnHCle0.05 M
sodium acetate, using 10 vols of extraction buffer per gram of
tissue19. A protease inhibitor cocktail was included containing 5mM
benzamidine hydrochloride, 0.4mMphenylmethylsulfonyl ﬂuoride,
10 mM N-ethylmaleimide, 0.1 M ε-amino-n-caproic acid and 0.01 M
Na2EDTA. Each one of the extracts was stored at 20C until use.
Zymographic examination of MMP-2 and MMP-9
The presence and gelatinolytic activity of MMP-2 and -9 was
estimated using zymographic techniques as previously described20.
Gels were scanned on a digital scanner (Hewlett Packard, ScanJet
6100 C/T), using the Adobe Photoshop 7 and analyzedwith the Image
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in arbitrary units (pixels). All samples were run in duplicate.
Western blot analysis
Extracts were subjected to Sodium dodecyl sulfate-
Polyacrylamide gel (SDS-PAGE) (T: 10%, C: 2.7%), using denaturing
conditions for MMPs and non-denaturizing conditions for Collagen
II as previously described21. After electrophoresis, the gels were
immersed in 0.15 M iodoacetamide in 0.05 M TriseHCl pH 8.3 for
15 min at room temperature to block free b-mercaptoethanol.
Thereafter, the protein bands were electrotransferred to Immobilon
Polyvynilidine ﬂuoride (PVDF) membranes at constant current of
200 mA at 4C for 45 min in 0.05 M TriseGlycine pH 8.3. The
membranes were blocked with 5% dry skimmed milk in Phosphate
buffer saline-Tween 20 (PBS-T) and incubated with the respective
monoclonal antibody in an appropriate dilution in PBSeTween 20
for 16 h at 4C. The following primary monoclonal antibodies were
used: MMP-2 Abcam (ab7032, 1:500), MMP-9 Abcam (ab119906,
1:500), MMP-13 Abcam (ab 58836, 1:1000) and Collagen type II
Abcam [5B2.5] (ab 3092, 1:500). After repeated washings with
PBSeTween 20, the membranes were incubated with second
antibody [Anti-mouse IgG e HRP conjugated (whole molecule,
afﬁnity puriﬁed) (SigmaeAldrich), A4416, 1:5000] for 1 h at room
temperature. The immunoreacting bands were visualized by
enhanced chemiluminescence method (ECL), according to the
manufacturer’s instructions (Pierce, ThermoScientiﬁc) and by
exposure to Fujiﬁlm X-ray ﬁlm.
RNA extraction and cDNA synthesis
Knee cartilage was pulverized in liquid nitrogen and subjected
to total RNA extraction, using the RNeasy Mini Kit (QIAGEN,
Dusseldorf, Germany), as described by the manufacturer and
treated with RNase-free DNase (QIAGEN, Dusseldorf, Germany) to
remove contaminating genomic DNA. The concentration of total
RNA was determined using nanodrop spectrophotometer (TECAN,
Switzerland). First-strand cDNA was synthesized from total RNA
according to the manufacturer’s instructions (Takara, Japan).
Real time-polymerase chain reaction (RT-PCR) analysis
Real time PCR was performed using the LightCycler2.0 apparatus
(Roche, Mannheim, Germany). Primer and housekeeping genes
were ordered from VBC BIOTECH (Austria). PCR ampliﬁcation was
carried out using LightCycler capillaries (Roche) at a ﬁnal volume of
20 ml including 10 mL of SYBR Green PCR Master Mix (QIAGEN,
Dusseldorf, Germany), plus 1.3 mL of each primer (20 pmol/ml) and
50 ng template DNA. PCR was performed according to the following
protocol: 95C for 5 min 1 cycle, followed by 40 cycles of 95C for
10 s and 60C for 30 s, and 1 cycle of 95C 10 s, 60C 2 min, 95C 0 s
continuous, and ﬁnally 1 cycle cooling at 40C for 30 s. Each reaction
was run in duplicate. The levels of the genes of interest were
normalized to Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) using the formula 2-Delta–Delta Cycle Threshold (DDCT),Table I
Primers used in the present study
MMP-2 MMP-9
Forward 50-CATTTGATGGCAAGGATGGACTC-30 50-GGTGT
Reverse 50-GCCATCAGCGTTCCCATACTTTAC-30 50-GAGCG
MMP-13 COL2A1
Forward 50-CACCTGATTCTTGCGTGCTA- 50-ACTGG
Reverse 50-GTGGCTCCCCATACATGAAC-30 50-CCACAwhere DDCT¼ DCT (sample)  DCT (calibrator) and DCT is the CT of
the housekeeping gene (GAPDH) subtracted from the CT of the
target gene. Melt curve analysis excluded primer-dimer artifacts.
The speciﬁcity of the products was conﬁrmed by agarose electro-
phoresis. Primers used are presented in Table I.
Statistical analysis
Comparison of data from two groups of mice was performed
using the Student’s t test. When more than a two-group compar-
isonwas required the results were analyzed using ANOVA. Data are
reported as means with 95% conﬁdence intervals (CIs) to describe
uncertainty of the estimates. A P value of less than 0.05 was
considered statistically signiﬁcant. All analyses were performed
with GraphPad Prism 5.0 (GraphPad Software, Inc, La Jolla, CA,
USA).
Results
Body-weight of mice fed WTD for 24 weeks
Theweights of C57BL/6, LCAT/ and apoA-I mice fedWTDwere
monitored at week 0, 6, 12, 24.
As expected, C57BL/6 mice showed an increase in their body-
weight during the course of the experiment. At week 6, C57BL/6
mice had an average body-weight of 31.8  1.7 g (23.5  3.9%
increase, as compared to their starting weight of 25.8 1 at week 0,
P< 0.0001), at week 12 their body-weight was already 35.3 0.6 g,
while at week 24 it increased further to 42.8  1.7 g (66.7  5.6%
increase, as compared to their starting weight at week 0,
P < 0.0001).
ApoA-I/ mice showed a similar to C57BL/6 mice increase in
their body-weights during the course of the experiment. Speciﬁ-
cally, at week 6 of the experiment, the apoA-I/ mouse group had
an average body-weight of 26.9  1.3 g (24.8  2.6% increase as
compared to their starting weight of 21.5  0.7 g at week 0,
P< 0.0001). At week 12, their average body-weight was 31.9 1.3 g
while at week 24, their body-weight further increased to
41.5  1.1 g (98.1  3.2% increase, as compared to their starting
weight at week 0, P < 0.0001).
Interestingly, LCAT/ mice were signiﬁcantly more sensitive to
the development of diet-induced obesity compared to the C57BL/6
and the apoA-I/ mice. At week 6 of the experiment, the LCAT/
mouse group had an average body-weight of 32.4  1.6 g
(38.3  2.3% increase as compared to their starting weight of
23.4 0.9 g at week 0, P< 0.0001). At week 12, their average body-
weight was 42.21.1 gwhile at week 24, their body-weight further
increased to 50.5  1.9 g (116.5  8.4% increase, as compared to
their starting weight at week 0, P < 0.0001).
Plasma lipid levels of mice fed WTD for 24 weeks
Fractionation of plasma lipoproteins by density gradient ultra-
centrifugation followed by determination of total cholesterol,
triglycerides, and phospholipids in the different density fractionsGAPDH
AGCACAACAGCTGACTACGA-30 50-TGTGTCCGTCGTGGATCTGA-30
GCCCTCAAAGATGAA-30 50-TTGCTGTTGAAGTCGCAGGAG-30
TAAGTGGGGCAAGAC-30
CCAAATTCCTGTTCA-30
Table II
Distribution and composition of plasma lipoproteins in C57BL/6, LCAT/ and
apoA-I/ mice that were fed WTD for 24 weeks. Concentrations in each lipoprotein
fraction are expressed in mg/dl
C57BL/6 LCAT/ ApoA-I/
Chol TG Chol TG Chol TG
Chyl/VLDL 0.0 0.2 12.9 10.0 1.5 0.5
IDL/LDL 3.0  0.9 1.1  0.3 14.5  4.1 6.5  3.1 1.9  0.4 0.5  0.2
HDL 16.1  4.1 0.5  0.1 2.2  1.4 1.0  0.2 1.7  0.3 0.1  0.0
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bution and composition of plasma lipoproteins of mice fedWTD for
24 weeks. Speciﬁcally, in LCAT-deﬁcient mice most of the choles-
terol was found in the chylomicron/very low density lipoprotein
(VLDL) and intermediate density lipoprotein (IDL) density fractions
while HDL cholesterol was signiﬁcantly reduced (Table II). InFig. 1. Histological analysis with the use of H&E stain showing that the articular cartilage of L
knee joint of a C57BL/6 mouse that also consumed WTD is normal (C). The H&E results are in
stain) are reduced in the cartilage of the LCAT (D) and apoA-I (E) deﬁcient mice that receive
articular surface of the femoral condyles of LCAT/ (G) and apoA-I/ (H) mice fed WTD for
WTD that is smoother (I). The bone marrow of the LCAT/ (J) and the apoA-I/ (K) mice th
comparison to the C57BL/6 animals that were also fed WTD (L) (yellow arrows point at theC57BL/6 mice the vast majority of cholesterol was distributed in the
HDL density fractions. Not surprisingly, in apoA-I-deﬁcient mice
HDL cholesterol was almost diminished. Both apoA-I/ and C57BL/
6 mice had low levels of triglyceride-rich chylomicrons and VLDL.
The chylomicron/VLDL fraction of LCAT/ mice had also a much
higher concentration of triglycerides consistent with the higher
steady-state triglyceride levels in the plasma of these mice
(Table II).
Histological and mCT analyses
Histological examination revealed that cartilage ﬁbrillation,
vertical clefts, chondrocyte clustering and decreased proteoglycan
content were signiﬁcantly augmented in the knee joints of the LCAT
and the apoA-I-deﬁcient mice fed WTD compared to the other
groups (P < 0.0001, for all correlations) [Figs. 1(AeF) and 2(A)]
(Table III). In parallel with the histological results, mCT analysisCAT-deﬁcient (A) and apoA-I (B) deﬁcient mice displays osteoarthritic changes, whereas
line with the Safranin O/Fast green ﬁndings, revealing that the proteoglycan levels (red
d WTD but not in the C57BL/6 (F). (Scale bar ¼ 100 mm). mCT analysis showing that the
24 weeks is rough (arrows) in contrast to the articular surface of the C57BL/6 mice fed
at were fed WTD for 24 weeks, displays signiﬁcantly elevated number of adipocytes in
bone marrow adipocytes). (Scale bar ¼ 1 mm).
Fig. 2. (A) Error bar showing the means with 95% CIs of mouse OARSI scores of the different groups examined. (B) Graphic presentation of the means and the 95% CIs of bone
marrow adipocytes of each animal group. Each group contained six mice. The OARSI score and the number of bone marrow adipocytes were signiﬁcantly elevated in the LCAT and
the apoA-I-deﬁcient mice that were fed WTD in comparison to the other animal groups [(*): P < 0.0001].
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LCAT/mice that were fedWTDwas rough, in contrast to the joint
surface of the other groups that was smoother [Fig. 1(GeI)].
Morphological analysis of our samples uncovered the presence
of signiﬁcantly elevated number of adipocytes in the bone marrow
of the LCAT/ and the apoA-I/ mice fed WTD, compared to the
bone marrow of the other experimental animal groups (P < 0.0001,
for all comparisons) [Figs. 1(JeL) and 2(B)] (Table III).
Biochemical and molecular analyses
Zymographic analysis showed that the gelatinolytic activity of
MMP-2 and MMP-9 was signiﬁcantly higher in the LCAT/ and the
apoA-I/ mice that were fed WTD, compared to the C57BL/6 mice
fed WTD [Figs. 3(Α, Β)ﬁg3 and 4(A, B)] or CD and the LCAT/ and
apoA-I/mice fed CD (not shown) (P< 0.0001, for all correlations).
In harmony with the zymorgaphic results, western blotting also
showed that the protein levels of MMP-2, MMP-9 and MMP-13
were signiﬁcantly elevated in the LCAT/ and the apoA-I/
animals fed WTD as compared to the other experimental groups
[Figs. 3(C, D) and 4(C, D) (mice on WTD)]. Not surprisingly, the
protein levels of Collagen type II were remarkably reduced in the
cartilage of the LCAT/ and the apoA-I/ mice in comparison to
the type II Collagen levels of the other groups tested (P< 0.0001, for
all correlations) [Fig. 5(AeD) (mice on WTD)].
Our results obtained from the zymographs and the western
blots were supported by experiments at the mRNA level. Indeed,
RT-PCR analyses revealed that mRNA levels of MMP-2, MMP-9 and
MMP-13 were signiﬁcantly augmented, whereas COL2A1 levels
were considerably reduced in the LCAT/ mice fed WTD in
comparison to the other animal groups (P < 0.0001, for all corre-
lations) [Fig. 5(E) (mice onWTD)]. The apoA-I/mice fedWTD hadTable III
Mouse OARSI scores and number of bone marrow adipocytes of the different mouse gro
deviation)
LCAT/, WTD LCAT/, CD
Mouse OARCI score Median 4 0
Mean 3.667 0.25
Range 3e4 0e1
CI (95%) 3.125e4.209 0.189e0.689
Number of BM adipocytes Median 35.5 1.5
Mean 35.83 1.33
Range 29e44 0e3
CI (95%) 24.92e42.25 0.062e2.06signiﬁcantly increased levels of MMP-2, MMP-9 and MMP-13 in
comparison to the C57BL/6 mice fed WTD (P ¼ 0.0168, 0.0107 and
0.0107, respectively). The expression levels of COL2A1 were
remarkably reduced in the apoA-I/ mice fed WTD compared to
the C57BL/6 that also consumed WTD (P ¼ 0.0236) [Fig. 5(F)]. The
expression levels ofMMP-2,MMP-9 andMMP-13were signiﬁcantly
elevated and COL2A1 was remarkably reduced in the apoA-I/
mice fedWTD as compared to the apoA-I/ and C57BL/6 mice that
were under CD (P < 0.0001, for all correlations) (data not shown).
Discussion
In the past few years a considerable number of studies have
reported that metabolic factors, namely hypertension, hypercho-
lesterolemia, blood glucose and insulin levels are related to OA in
an obesity-independent fashion, supporting the hypothesis that OA
has a metabolic aspect in its aetiopathogenesis22e24. However, the
systemic regulation of OA development is very complicated.
Indeed, recent data suggest that leptin a hormone that is primarily
synthesized by adipose tissue and is associated with body mass
index has catabolic effects on chondrocytes causing OA25,26. On the
contrary, other studies on animalmodels have shown that impaired
leptin signaling does not result in OA development27. Other adi-
pokines such as adiponectin and resistin are also implicated in OA
pathogenesis28e30.
In this vein, decreased levels of HDL-C have been observed in
several systemic conditions including OA7,8. However, the role of
HDL in the pathogenesis of OA deserves furtherer exploration since
it has been recently realized by the medical community that HDL
particle functionality is more important for plasma and tissue lipid
homeostasis than simply HDL-C levels31. Indeed, HDL possesses
a number of anti-inﬂammatory and anti-oxidant properties thatups that used in the present study (abbreviations: BM, bone marrow; SD, standard
ApoA-I/, WTD ApoA-I/, CD C57BL/6, WTD C57BL/6, CD
3.5 0.25 0.25 0
3.333 0.333 0.583 0.167
2e4 0e1 0e2 0e0.5
2.476e4.190 0.095e0.762 0.257e1.424 0.104e0.438
45 2 2.5 0.5
45.33 1.5 2.5 0.667
38e53 0e3 1e4 0e2
39.12e51.55 0.214e2.785 1.053e3.947 0.19e1.524
Fig. 3. (A) Gelatin zymography results obtained from three C57BL/6 and three LCAT/mice, fed WTD for 24 weeks. (B) Semi-quantitative analysis of pro and active forms of MMP-2
and MMP-9. Each bar shows the mean value of all (n ¼ 6) mice cartilages examined and the 95% CIs. (C) Analysis of the MMP levels of the cartilage of three LCAT-deﬁcient and three
C57BL/6 mice with western blotting. The protein levels of MMP-2, -9 and -13 were signiﬁcantly higher in the LCAT/ compared to the C57BL/6 mice that were fed WTD for
24 weeks. (D) Graphic presentation of the mean values of all (n ¼ 6) mice cartilages examined and the 95% CIs. Signal intensities were determined by densinometric analysis of
treated blots and values calculated as the ratio of MMP/beta-actin. All samples contained the same amount of protein and were run in duplicate. The vertical line marks splicing of
a single western blot membrane to increase the clarity of the presentation. [(*): P < 0.0001].
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For example, immature or dysfunctional HDL particles may
contribute to HDL-C levels in plasma31,32. Given that LCAT and
apoA-I are key enzymes in the maturation of HDL, in an effort to
further explore the involvement of HDL in OA pathogenesis in the
present work we employed experimental animal models to assess
the role of these molecules in the development of OA. Our ﬁndingsFig. 4. (A) Zymographic analysis of three C57BL/6 and three apoA-I/ mice, fed WTD for 2
analyzed. Each bar represents the mean value of all (n ¼ 6) mice cartilages examined and th
three apoA-I-deﬁcient and three C57BL/6 mice that consumed WTD for 24 weeks. The prote
the C57BL/6 mice. (D) Graphic presentation of the mean values of all (n ¼ 6) mice cartilages e
of treated blots and values calculated as the ratio of MMP/beta-actin. All samples contained t
a single western blot membrane to increase the clarity of the presentation. [(*): P < 0.0001provide mechanistic evidence that dysfunctional HDL is associated
with the pathophysiology of OA.
Body-weight measurements did not reveal any signiﬁcant
differences between the LCAT/ and wild-type C57BL/6 mice fed
CD. In line with these results, histological, histochemical and mCT
analyses of knee cartilage did not show notable morphologic
changes in both groups. The expression levels of the hyaline4 weeks. (B) The pro and active forms of MMP-2 and MMP-9 were semi-quantitatively
e 95% CIs. (C) Western blotting evaluation of the MMP levels of cartilage obtained from
in levels of MMP-2, -9 and -13 were signiﬁcantly higher in the apoA-I/ compared to
xamined and the 95% CIs. Signal intensities were determined by densitometric analysis
he same amount of protein and were run in duplicate. The vertical line marks splicing of
].
Fig. 5. Western blot analysis for Collagen type II from three LCAT/ (A) and three apoA-I/mice (C) and that were fed WTD for 24 weeks in parallel to C57BL/6 mice that were also
fed WTD for 24 weeks. The protein levels of Collagen type II were signiﬁcantly higher in the LCAT/ and the apoA-I/ compared to the C57BL/6 mice (B and D, respectively). Each
bar represents the mean value of all (n ¼ 6) mice cartilages examined and the 95% CIs. All samples contained the same amount of protein and were run in duplicate. The vertical line
marks splicing of a single western blot membrane to increase the clarity of the presentation. MMPs (MMP-2, MMP-9, MMP-13) and Collagen type II mRNA levels for the LCAT/ and
the apoA-I/ mice that were placed in WTD compared to C57BL/6 mice, as determined by real time PCR analysis using primers speciﬁc for each gene and normalized against
GAPDH (E and F, respectively). Error bars represent, the mean value and the 95% CIs expressed as arbitrary units. All correlations were statistically signiﬁcant [(*): P < 0.05 and (**):
P < 0.0001].
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13 were also examined. Collagen type II is the major element of the
hyaline cartilage extracellular matrix and consequently decreased
levels of this protein reﬂect cartilage breakdown. On the other
hand, MMP-2, -9 and -13 facilitate cartilage degradation and hence
are elevated in OA. In the present study, we observed that the levels
of the examined MMPs and Collagen type II of the two animal
groups were similar. Taken together these ﬁndings propose that the
deﬁciency of LCAT per se does not affect body-weight and plasma
lipoproteins level, and has not direct impact on cartilage quality
and structure and thus on the development of OA in mice.
We have recently reported that the lipoprotein transport system
serves as an important peripheral mediator of diet-induced obesity
and that LCAT and apoA-I knock-out mice fed WTD are sensitized
toward hepatic triglyceride accumulation and non-alcoholic fatty
liver disease development12,13. Intrigued by these ﬁndings, in the
present study we proceeded to examine the effects of long-term
insult by WTD (high-fat) on the pathobiology of OA in LCAT/,
apoA-I/ and C57BL/6 control mice. We chose to use this type of
diet, since it corresponds to the average daily energy consumption
seen in western societies.
LCAT-deﬁcient mice fed WTD for 24 weeks were more suscep-
tible than the C57BL/6 controls in the development of diet-induced
obesity. The cholesterol of LCAT/micewas principally detected in
the chylomicron/VLDL/IDL fractions, suggesting that these animals
have very low levels of circulating HDL. On the contrary, plasmacholesterol of the C57BL/6 mice was found in the HDL fraction.
Surprisingly, the Chyl/VLDL and the IDL/LDL cholesterol levels of
the LCAT/ at week 24 were signiﬁcantly higher than C57BL/6
control mice. This increase could be attributed to the deterioration
of hepatic function and architecture observed in these mice12.
Interestingly, the morphological and biochemical/molecular anal-
yses of the hyaline cartilage revealed the presence of cartilage
degeneration in the LCAT/ fed WTD suggesting that LCAT deﬁ-
ciency and hence the inability to produce mature HDL, may
predispose to the development of OA in mice following chronic
insult by high-fat diet. Previous studies have shown that high-fat
diet results in OA development in wild-type mice30,34,35. It is
possible that the lack of evident OA in our wild-type mice may be
due to the type and the duration of the high-fat insult. Indeed, in
those studies either the energy from fats was very high (60%
compared to 42% in our study) or mice were placed in high-fat diet
for longer time (42 weeks, compared to 24 weeks in our study).
In an attempt to further conﬁrm the functional participation of
HDL in the pathobiology of OAwe also studied mice lacking apoA-I,
which have no functional classical HDL circulating in their blood.
Our morphological and biochemical/molecular data revealed that
the apoA-I/ mice fed WTD developed OA. Apparently, the
development of OA in the apoA-I/ non-obese mice suggests that
it is possible that perturbations in HDL metabolism rather than
excess mechanical stress trigger the disease in these mice. This
ﬁnding is in line with a recent study having shown signiﬁcantly
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recent ﬁnding that lipid droplets accumulate within osteoarthritic
chondrocyte due to impaired expression and function of choles-
terol efﬂux molecules (namely ApoA-I and Liver X Receptors) could
explain, at least partially, the damage of articular cartilage in OA36.
The OA of the apoA-I/mice may result from the lack of functional
HDL or from the compromised cholesterol efﬂux that leads to the
accumulation of lipid droplets in the chondrocytes, which in turn
might trigger degenerative processes. We hypothesize that the
impaired maturation of HDL might be directly responsible for the
development of OA in the LCAT and the apoA-I knock-out mice fed
WTD. We have very recently shown that LCAT and apoA-I deﬁ-
ciency facilitates hepatic diet-induced deposition of triglycerides
and non-alcoholic fatty liver disease development in mice12,13.
These ﬁndings imply that liver damage and/or systemic inﬂam-
mation may predispose to cartilage destruction raising the possi-
bility that altered HDL metabolism may be indirectly linked to OA.
Our work does not address this issue; further studies are required
in order to clarify the direct and/or indirect effects of altered HDL
metabolism on articular cartilage. Notably, the causative role of
HDL in the pathogenesis of OA that we have identiﬁed in the
present study may also explain the increased risk of patients with
OA toward cardiovascular disease24.
Another noteworthy result of our study was that bone marrow
from LCAT/ and apoA-I/ mice fed WTD contained signiﬁcantly
elevated number of adipocytes than the bone marrow of the other
experimental groups. Taking into account the age of the mice used
in the present study (10e12 weeks) this was an unexpected
ﬁnding because the accumulation of adipocytes in the tibial and
femoral bone marrow of the C57BL/6 mice is evident after the
achievement of peak bone mass, at the age of 16e24 weeks37.
Indeed, we did not observe considerable bone marrow adiposity in
mice fed CD [Fig. 2(A), Table III]. Our observations are in symphony
with previous studies having shown that cancellous bone of
femoral heads of OA patients contained twice as much fat per unit
compared to healthy individuals38. A plausible explanation for this
is that since bone marrow fat functions in a fashion similar to
white adipose tissue it produces and secretes adipokines (e.g.,
leptin, adiponectin, resistin) that may have an effect on articular
cartilage and thus lead to the development of OA39. Obviously,
further studies are required in order to substantiate this
hypothesis.
It is well-established that OA is associated with obesity, insulin
resistance, dyslipidemia and cardiovascular pathologies24. For this
reasons, it has been proposed that OA could be another constituent
of the metabolic syndrome6,7. Obesity and reduced HDL levels are
two of the components of metabolic syndrome in humans. The
data presented in our manuscript place HDL as a key-component
in OA pathogenesis by indicating that the reduced HDL levels of
patients with metabolic syndrome contribute to OA development.
Overall, our ﬁndings propose a functional cross-talk between HDL
metabolic pathway and cartilage biology further supporting
the notion that OA has a strong metabolic facet in its
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